← VIP Peptide overview

VIP Peptide Dosage & Reconstitution Guide

Research and educational use only — not medical advice, and not for human consumption. The figures below are summarized from public sources, product labeling, and community reports, and are not a prescription or a substitute for a qualified clinician.

Typical dose
Experimental Dos…
Route
Intranasal
Frequency
up to 4 sessions daily

Dosing guide

Level Dose Notes
Standard (compounded protocol) 50 mcg one spray, 4× daily

Timing & cycling

Intranasal spray. The published CIRS protocol doses 4× daily; respiratory research has explored inhaled forms.

Cycle length. CIRS protocols run 30+ days under practitioner supervision with labs before and during.

Storage & handling

Store the made-up nasal solution in the refrigerator and replace it roughly monthly — peptides in solution degrade at room temperature. Keep unopened powder cool, dry, and dark.

Key points

  • Legitimate use runs through compounding pharmacies with a prescription; research-grade VIP for injection has no human self-use protocol.
  • Very short half-life is why dosing is small and frequent.

What to monitor

The practitioner protocol checks lipase and cortisol before and during use — VIP is a systemic hormone, not a casual spray.

Legal & prescription status

No legal prescription exists. It is an unapproved research chemical, sold only for laboratory research and labelled 'not for human consumption.' It is not FDA-approved for any human use.

References

  1. pubmed.ncbi.nlm.nih.gov
  2. pubmed.ncbi.nlm.nih.gov
  3. pubmed.ncbi.nlm.nih.gov
  4. pubmed.ncbi.nlm.nih.gov
  5. pubmed.ncbi.nlm.nih.gov
  6. pubmed.ncbi.nlm.nih.gov
  7. pubmed.ncbi.nlm.nih.gov

This guide is for research and educational purposes only. It is not medical advice and does not describe a product approved for human use. Always consult a qualified healthcare professional before considering any peptide protocol.